Bubs Secures Permanent US FDA Approval for Infant Formula

Key points

• Permanent FDA approval for Bubs Goat, Bubs 365 Day Grass Fed, and Bubs Essential
• Bubs among few non-US manufacturers authorized to supply US infant formula market
• Opportunity to expand product innovation and enter US private label segment

Full summary

Bubs Australia Ltd announced it has received permanent regulatory approval from the US FDA for its infant formula products: Bubs Goat, Bubs 365 Day Grass Fed, and Bubs Essential. This approval confirms Bubs' compliance with US safety, nutritional, and quality standards, positioning the company among a select group of international manufacturers authorized to supply the US market. The approval not only strengthens Bubs' competitive position but also opens up opportunities for product innovation and potential participation in the US private label segment.